Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.41 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.41 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.41 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7370094 | 0.82 | TRPV1 (0.61) | ALDH1A1TSHRTRPV1 | |
| SCHEMBL6681923 | 0.82 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1TSHRTRPV1 | |
| SCHEMBL2007696 | 0.81 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL10165058 | 0.81 | ALDH1A1 (0.51) | ALDH1A1GRM2 | |
| SCHEMBL6185932 | 0.81 | ALDH1A1 (0.51) | ALDH1A1L3MBTL1 | |
| SCHEMBL4615592 | 0.80 | ALDH1A1 (0.74) | ALDH1A1 | |
| SCHEMBL24692562 | 0.79 | ITGA4 (0.44) | — | |
| SCHEMBL2574214 | 0.79 | CYP1A2 (0.56) | ALDH1A1TSHRTRPV1 | |
| SCHEMBL8232973 | 0.79 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1 | |
| SCHEMBL5718743 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021192-A1 | PROTEINS HAVING A COVALENT WARHEAD | TOPAZ THERAPEUTICS INC (US) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021192-A1 | PROTEINS HAVING A COVALENT WARHEAD | RIOX2, ORC3, DCLRE1A | ALDH1A1 3714/4885GRM2 1941/4885CA1 2825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.